Cell Biomarkers To Distinguish Deadly From Less Aggressive HPV Oral Cancers October 3, 2016 MedicalResearch.com interview with: Elizabeth Franzmann, M.D. Scientific Founder and Chief Scientific Officer Vigilant Biosciences MedicalResearch.com: What is the background for this study? Response: Head and neck cancer involves cancers of the oral cavity, oropharynx and larynx. It is difficult to treat.
Recent Comments